85 related articles for article (PubMed ID: 18046444)
1. Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Vago P; Travade P; Tchirkov A
Leukemia; 2008 Jun; 22(6):1291-3. PubMed ID: 18046444
[No Abstract] [Full Text] [Related]
2. Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Gouas L; Bay JO; Vago P; Tchirkov A
Leuk Res; 2009 Dec; 33(12):1623-6. PubMed ID: 19487028
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine.
Balakrishnan K; Wierda WG; Keating MJ; Gandhi V
Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456
[TBL] [Abstract][Full Text] [Related]
4. Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Merkel O; Wacht N; Sifft E; Melchardt T; Hamacher F; Kocher T; Denk U; Hofbauer JP; Egle A; Scheideler M; Schlederer M; Steurer M; Kenner L; Greil R
Leukemia; 2012 Dec; 26(12):2508-16. PubMed ID: 22743622
[TBL] [Abstract][Full Text] [Related]
5. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
6. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Freeman SN; Bepler G; Haura E; Sutphen R; Cress WD
J Natl Cancer Inst; 2005 Jul; 97(14):1088-9; author reply 1093-5. PubMed ID: 16030308
[No Abstract] [Full Text] [Related]
7. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Vargas RL; Felgar RE; Rothberg PG
J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
[No Abstract] [Full Text] [Related]
8. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Iglesias-Serret D; Coll-Mulet L; Santidrián AF; Navarro-Sabaté A; Domingo A; Pons G; Gil J
J Natl Cancer Inst; 2005 Jul; 97(14):1090-1; author reply 1093-5. PubMed ID: 16030310
[No Abstract] [Full Text] [Related]
9. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Nenning UC; Eckert C; Wellmann S; Barth A; Henze G; Seeger K
J Natl Cancer Inst; 2005 Jul; 97(14):1091-2; author reply 1093-5. PubMed ID: 16030311
[No Abstract] [Full Text] [Related]
10. Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.
Tobin G; Skogsberg A; Thunberg U; Laurell A; Aleskog A; Merup M; Sundström C; Roos G; Nilsson K; Rosenquist R
Leukemia; 2005 May; 19(5):871-3. PubMed ID: 15759030
[No Abstract] [Full Text] [Related]
11. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Dicker F; Rauhut S; Kohlmann A; Kern W; Schoch C; Haferlach T; Schnittger S
J Natl Cancer Inst; 2005 Jul; 97(14):1092-3; author reply 1093-5. PubMed ID: 16030312
[No Abstract] [Full Text] [Related]
12. The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.
Coenen S; Pickering B; Potter KN; Johnson PW; Stevenson FK; Packham G
Haematologica; 2005 Sep; 90(9):1285-6. PubMed ID: 16154859
[TBL] [Abstract][Full Text] [Related]
13. [Effect of vascular endothelial growth factor on apoptosis and expression of Bcl-2 and Mcl-1 in acute leukemia cells].
Liao XL; Xie XT; Li BS; Li L; Yang LL
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):491-5. PubMed ID: 17178043
[TBL] [Abstract][Full Text] [Related]
14. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
Bogner C; Sandherr M; Perker M; Weick K; Ringshausen I; Peschel C; Decker T
Ann Hematol; 2006 Jul; 85(7):458-62. PubMed ID: 16538501
[TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
17. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
[TBL] [Abstract][Full Text] [Related]
19. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.
Rust R; Harms G; Blokzijl T; Boot M; Diepstra A; Kluiver J; Visser L; Peh SC; Lim M; Kamps WA; Poppema S; van den Berg A
J Clin Pathol; 2005 May; 58(5):520-4. PubMed ID: 15858125
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
